- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03876431
Exercise Device in Total Knee Arthroplasty
Investigation the Effectiveness of Exercise Device in the Rehabilitation of Total Knee Arthroplasty
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Fatih
-
Istanbul, Fatih, Turkey, 34147
- Istanbul Faculty Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients with TKA surgery due to the diagnosis of knee OA Between the ages of 45-80 years Patients with no difference over 5 cm in the extremity before and after surgery
Exclusion Criteria:
Revision TKA, Previous unicompartmental arthroplasty or tibial osteotomy, Hemophilia, Uncontrolled hypertension Rheumatic diseases, Lower extremity fractures and tumors, Neurological diseases leading to muscle weakness in the lower limbs, Patients with emotional and cognitive problems
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Traditional Exercise Group
Only traditional exercises will be performed in the early post-op period.
|
After total knee replacement surgery, exercise program including strengthening, stretching and patient training will be applied.
|
|
Experimental: Easy-Flex Group
Easy-Flex group will be treated with the Easy-Flex device in addition to the traditional exercise program.
|
After total knee replacement surgery, exercise program including strengthening, stretching and patient training will be applied.
The Easy-Flex device will be used to increase knee flexion and extension ROM.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change range of motion
Time Frame: Assessment is performed at pre-op and post-op second and sixth weeks rehabilitation program.
|
Range of motion of knee flexion and extension
|
Assessment is performed at pre-op and post-op second and sixth weeks rehabilitation program.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
WOMAC
Time Frame: Assessment is performed at pre-op and post-op second and sixth weeks rehabilitation program.
|
Measure of symptoms and physical disability
|
Assessment is performed at pre-op and post-op second and sixth weeks rehabilitation program.
|
|
Satisfaction levels of the patients
Time Frame: At sixth week
|
Satisfaction levels of the patients with Global Rating of Change Score
|
At sixth week
|
|
Short Form 12 (SF-12)
Time Frame: Assessment is performed at pre-op and post-op second and sixth weeks rehabilitation program.
|
SF-12 is used to assess physical and mental health-related quality of life.
The high scores are positively correlated with the high quality of life.
|
Assessment is performed at pre-op and post-op second and sixth weeks rehabilitation program.
|
|
10 meter walking test
Time Frame: Assessment is performed at pre-op and post-op second and sixth weeks rehabilitation program.
|
To test comfortable or maximal walking speed
|
Assessment is performed at pre-op and post-op second and sixth weeks rehabilitation program.
|
|
5 sit to stand
Time Frame: Assessment is performed at pre-op and post-op second and sixth weeks rehabilitation program.
|
To measure performance of lower extremity
|
Assessment is performed at pre-op and post-op second and sixth weeks rehabilitation program.
|
|
NPRS (Numerical Pain Rating Scale)
Time Frame: Assessment is performed at pre-op and post-op second and sixth weeks rehabilitation program.
|
The levels of pain intensity measured using NPRS (Numerical Pain Rating Scale).
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable").
|
Assessment is performed at pre-op and post-op second and sixth weeks rehabilitation program.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Derya Çelik, Professor, Istanbul University Faculty of Health Sciences
- Principal Investigator: Zeynal Yasacı, Istanbul University Faculty of Health Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 12/01/2018-17939
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.